Works matching DE "IDARUBICIN"

Results: 168
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 3, p. 700, doi. 10.3390/jcm14030700
    By:
    • Battaglia, Giulia;
    • Lazzarotto, Davide;
    • Tanasi, Ilaria;
    • Gurrieri, Carmela;
    • Forlani, Laura;
    • Mauro, Endri;
    • Capraro, Francesca;
    • Ciotti, Giulia;
    • De Bellis, Eleonora;
    • Callegari, Chiara;
    • Tosoni, Luca;
    • Fanin, Matteo;
    • Morelli, Gian Luca;
    • Simio, Claudia;
    • Skert, Cristina;
    • Gottardi, Michele;
    • Zaja, Francesco;
    • Toffoletti, Eleonora;
    • Damiani, Daniela;
    • Fanin, Renato
    Publication type:
    Article
    13
    14

    Author reply.

    Published in:
    Internal Medicine Journal, 2014, v. 44, n. 8, p. 825, doi. 10.1111/imj.12506
    By:
    • Wei, A.;
    • Fleming, S.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Acute myeloid leukemia 7 years after aleukemic leukemia cutis.

    Published in:
    International Journal of Dermatology, 2015, v. 54, n. 4, p. 459, doi. 10.1111/ijd.12024
    By:
    • Narváez‐Moreno, Basilio;
    • Pereyra‐Rodríguez, José Juan;
    • Pulpillo‐Ruiz, Agueda;
    • Cabrera‐Pérez, Rocío;
    • Espigado‐Tocino, Idelfonso;
    • Conejo‐Mir, Julián
    Publication type:
    Article
    21
    22

    Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial.

    Published in:
    Annals of Hematology, 2015, v. 94, n. 4, p. 557, doi. 10.1007/s00277-014-2242-6
    By:
    • Röllig, Christoph;
    • Schäfer-Eckardt, Kerstin;
    • Hänel, Matthias;
    • Kramer, Michael;
    • Schaich, Markus;
    • Thiede, Christian;
    • Oelschlägel, Uta;
    • Mohr, Brigitte;
    • Wagner, Thomas;
    • Einsele, Hermann;
    • Krause, Stefan;
    • Bodenstein, Heinrich;
    • Martin, Sonja;
    • Stuhlmann, Reingard;
    • Ho, Antony;
    • Bornhäuser, Martin;
    • Ehninger, Gerhard;
    • Schuler, Ulrich;
    • Platzbecker, Uwe
    Publication type:
    Article
    23

    Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

    Published in:
    Annals of Hematology, 2014, v. 93, n. 6, p. 965, doi. 10.1007/s00277-014-2056-6
    By:
    • Willemze, R.;
    • Suciu, S.;
    • Muus, P.;
    • Halkes, C.;
    • Meloni, G.;
    • Meert, L.;
    • Karrasch, M.;
    • Rapion, J.;
    • Vignetti, M.;
    • Amadori, S.;
    • Witte, T.;
    • Marie, J.
    Publication type:
    Article
    24

    De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened 'GO question'.

    Published in:
    Annals of Hematology, 2013, v. 92, n. 10, p. 1309, doi. 10.1007/s00277-013-1780-7
    By:
    • Clavio, Marino;
    • Cruciani, Fabio;
    • Minetto, Paola;
    • Guolo, Fabio;
    • Ballerini, Filippo;
    • Marani, Carlo;
    • De Astis, Enrico;
    • Aquino, Sara;
    • Bergamaschi, Micaela;
    • Mitscheunig, Laura;
    • Grasso, Raffaella;
    • Colombo, Nicoletta;
    • Ghiggi, Chiara;
    • Lovera, Davide;
    • Pastori, Giordana;
    • Avenoso, Daniele;
    • Miglino, Maurizio;
    • Gobbi, Marco
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31

    Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia

    Published in:
    Hematological Oncology, 2020, v. 38, n. 5, p. 754, doi. 10.1002/hon.2806
    By:
    • Borlenghi, Erika;
    • Cattaneo, Chiara;
    • Cerqui, Elisa;
    • Archetti, Silvana;
    • Bertoli, Diego;
    • Bellotti, Daniela;
    • Gramegna, Doriana;
    • Soverini, Giulia;
    • Oberti, Margherita;
    • Schieppati, Francesca;
    • Pagani, Chiara;
    • Passi, Angela;
    • Sciumé, Margherita;
    • Farina, Mirko;
    • Carbone, Cecilia;
    • Crippa, Claudia;
    • Dalceggio, Daniela;
    • Tucci, Alessandra;
    • Rossi, Giuseppe
    Publication type:
    Article
    32

    Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 4, p. 531, doi. 10.1002/hon.2755
    By:
    • Zhou, Xinping;
    • Mei, Chen;
    • Zhang, Jin;
    • Lu, Ying;
    • Lan, Jianping;
    • Lin, Shengyun;
    • Zhang, Yuefeng;
    • Kuang, Yuemin;
    • Ren, Yanling;
    • Ma, Liya;
    • Wei, Juying;
    • Ye, Li;
    • Xu, Weilai;
    • Li, Kongfei;
    • Lu, Chenxi;
    • Jin, Jie;
    • Tong, Hongyan
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3 -ITD in NPM1 Mutated AML, Irrespectively of FLT3 -ITD Allelic Burden.

    Published in:
    Cancers, 2021, v. 13, n. 1, p. 34, doi. 10.3390/cancers13010034
    By:
    • Minetto, Paola;
    • Candoni, Anna;
    • Guolo, Fabio;
    • Clavio, Marino;
    • Zannier, Maria Elena;
    • Miglino, Maurizio;
    • Dubbini, Maria Vittoria;
    • Carminati, Enrico;
    • Sicuranza, Anna;
    • Ciofini, Sara;
    • Colombo, Nicoletta;
    • Pugliese, Girolamo;
    • Marcolin, Riccardo;
    • Santoni, Adele;
    • Ballerini, Filippo;
    • Lanino, Luca;
    • Cea, Michele;
    • Gobbi, Marco;
    • Bocchia, Monica;
    • Fanin, Renato
    Publication type:
    Article
    50